MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    Critical appraisal of economic evaluation of biomarkers used for screening dementia

    M. Azharuddin, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to assess the cost effectiveness of biomarkers used for early diagnosis of dementia disorders. Background: Dementia remains a…
  • 2022 International Congress

    Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19

    B. Lobb, K. Chung, A. Hiller, J. Quinn (Portland, USA)

    Objective: To retain a well-characterized longitudinal Parkinson’s Study, The Portland Oregon Pacific UDALL Center (PRE-PUC) cohort, during the pandemic years. Background: Although best known for…
  • 2022 International Congress

    Cognitive dysfunction in cervical dystonia

    M. Diepman, S. Rafee, M. Hutchinson, R. Sommers, F. O'Keeffe (Dublin 4, Ireland)

    Objective: To assess prevalence of anxiety and depression in patients with CD and investigate cognitive changes including social cognition and executive function. Background: Cervical dystonia,…
  • 2022 International Congress

    Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease

    E. Contaldi, L. Magistrelli, S. Gallo, C. Comi (Novara, Italy)

    Objective: The present study aimed to elucidate whether i) lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) can discriminate Parkinson's disease (PD) patients from healthy controls (HC);…
  • 2022 International Congress

    Relationship between cardiovascular autonomic failure and cognitive performance in the α-synucleinopathies: preliminary cross-sectional analysis of the NHSS registry

    N. Campese, L. Weissmantel, K. Kerer, F. Leys, G. Goebel, L. Zamarian, C. Raccagni, S. Eschlboeck, C. Eckhardt, V. Sidoroff, F. Krismer, R. Granata, M. Perez, J. Palma, P. Millar-Vernetti, R. Ceravolo, S. Kiechl, W. Poewe, K. Seppi, H. Kaufmann, L. Norcliffe-Kaufmann, G. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To compare cognitive performances of patients with α-synucleinopathies with or without cardiovascular dysautonomia. Background: Cardiovascular dysautonomia is a disabling non-motor feature of the α-synucleinopathies and may…
  • 2022 International Congress

    Correlations between cognitive impairments and brain abnormalities in Wilson disease: a systematic review

    A. Hausmann, S. Kannenberg, C. Hartmann, J. Caspers, A. Schnitzler (Duesseldorf, Germany)

    Objective: To provide an overview of brain regions involved in cognitive impairment (CI) in Wilson disease (WD) with the aim of understanding pathomechanisms. Background: WD…
  • 2022 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after 2 years Subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, C. Pons, N. Grunden, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and 2 years after STN-DBS and compare their results with other recognized cognitive scales. Background: Parkinson´s disease…
  • 2022 International Congress

    Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment

    DX. Deng, LT. Tan (Singapore, Singapore)

    Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and Parkinson's disease (PD). Background: Studies have shown that the serum levels…
  • 2022 International Congress

    Longitudinal study of clinical symptoms associated with psychosis in Parkinson’s disease without dementia

    J. Flanigan, M. Harrison, B. Shah, J. Patrie, K. Wyman-Chick, W. Dalrymple, S. Sperling, M. Barrett (Charlottesville, USA)

    Objective: Examine clinical features associated with psychosis among Parkinson’s disease (PD) patients without dementia. Background: Previously identified risk factors for PD psychosis include duration and…
  • 2022 International Congress

    Local Field Potential from Subthalamic Nucleus Correlate with Attentional Performance in Parkinson’s Disease

    MS. Rocha, A. Fim Neto, B. Bianqueti, J. de Luccas, D. Soriano, L. da Silva, F. Godinho (SAO PAULO, Brazil)

    Objective: To investigate a correlation between the subthalamic nucleus (STN) local field potentials (LFP) and attentional performance in Parkinson's disease (PD) patients. Background: Attentional deficits…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley